SpringerLink
Log in

Peritoneum and Broad Ligament

  • Chapter
  • First Online:
Gynecologic and Obstetric Pathology, Volume 2

  • 1422 Accesses

Abstract

The peritoneum is a site for diverse nonneoplastic and neoplastic disease processes including those encountered in many other organ systems in the body. Once proposed as part of the secondary Müllerian system, its role in the pathogenesis of primary serous carcinomas has recently been questioned. It has been postulated that primary Müllerian peritoneal/omental serous carcinoma is a metastasis from the similar tumor of the fallopian tubes. This theory, however, applies to serous carcinomas only, not tumors of any other Müllerian cell types. Far from being a mere receptacle for metastasis from other organ sites, the notion that the peritoneum and its derivatives serve as important source of primary peritoneal carcinomas remains a valid concept.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Egli G, Newton M. The transport of carbon particles in the human female reproductive tract. Fertil Steril. 1961;12:151–5.

    Article  CAS  PubMed  Google Scholar 

  2. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351:659–64.

    Article  CAS  PubMed  Google Scholar 

  3. Sohar E, Gafni J, Pras M, et al. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53.

    Article  CAS  PubMed  Google Scholar 

  4. Wu TI, Chang TC, Hsueh S, et al. Ovarian endometrioid carcinoma with diffuse pigmented peritoneal keratin granulomas: a case report and review of the literature. Int J Gynecol Cancer. 2006;16:426–9.

    Article  CAS  PubMed  Google Scholar 

  5. Chen KT, Kostich ND, Rosai J. Peritoneal foreign body granuloma to keratin in uterine adenoacanthoma. Arch Pathol Lab Med. 1978;102:174–7.

    CAS  PubMed  Google Scholar 

  6. Fukushima M, Sharpe L, Okagaki T. Peritoneal melanosis secondary to a benign dermoid cyst of the ovary: a case report with ultrastructural study. Int J Gynecol Pathol. 1984;2:403–9.

    Article  CAS  PubMed  Google Scholar 

  7. Dehner LP, Coffin CM. Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Semin Diagn Pathol. 1998;15:161–73.

    CAS  PubMed  Google Scholar 

  8. Clement PB, Young RH, Hanna W, et al. Sclerosing peritonitis associated with luteinized thecomas of the ovary. A clinicopathological analysis of six cases. Am J Surg Pathol. 1994;18:1–13.

    Article  CAS  PubMed  Google Scholar 

  9. Staats PN, McCluggage WG, Clement PB, et al. Luteinized thecomas (thecomatosis) of the type typically associated with sclerosing peritonitis: a clinical, histopathologic, and immunohistochemical analysis of 27 cases. Am J Surg Pathol. 2008;32:1273–90.

    Article  PubMed  Google Scholar 

  10. Kafiri G, Thomas DM, Shepherd NA, et al. p53 expression is common in malignant mesothelioma. Histopathology. 1992;21:331–4.

    Article  CAS  PubMed  Google Scholar 

  11. Henderson DW, Shilkin KB, Whitaker D. Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review. Am J Clin Pathol. 1998;110:397–404.

    Article  CAS  PubMed  Google Scholar 

  12. Vallerie AM, Lerner JP, Wright JD, et al. Peritoneal inclusion cysts: a review. Obstet Gynecol Surv. 2009;64:321–34.

    Article  PubMed  Google Scholar 

  13. Ben-Izhak O, Itin L, Feuchtwanger Z, Lifschitz-Mercer B, Czernobilsky B. Calcifying fibrous pseudotumor of mesentry presenting with acute peritonitis: case report with immunohistochemical study and review of literature. Int J Surg Pathol. 2001;9:249–53.

    Article  CAS  PubMed  Google Scholar 

  14. Hill KA, Gonzalez-Crussi F, Chou PM. Calcifying fibrous pseudotumor versus inflammatory myofibroblastic tumor: a histological and immunohistochemical comparison. Mod Pathol. 2001;14:784–90.

    Article  CAS  PubMed  Google Scholar 

  15. Nascimento AF, Ruiz R, Hornick JL, et al. Calcifying fibrous ‘pseudotumor’: clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor. Int J Surg Pathol. 2002;10:189–96.

    Article  PubMed  Google Scholar 

  16. Van Dorpe J, Ectors N, Geboes K, et al. Is calcifying fibrous pseudotumor a late sclerosing stage of inflammatory myofibroblastic tumor? Am J Surg Pathol. 1999;23:329–35.

    Article  PubMed  Google Scholar 

  17. Sigel JE, Smith TA, Reith JD, et al. Immunohistochemical analysis of anaplastic lymphoma kinase expression in deep soft tissue calcifying fibrous pseudotumor: evidence of a late sclerosing stage of inflammatory myofibroblastic tumor? Ann Diagn Pathol. 2001;5:10–4.

    Article  CAS  PubMed  Google Scholar 

  18. Lim C, McIlroy K, Briggs G, et al. Splenosis mimicking lymphoma. Pathology. 2007;39:183–5.

    Article  PubMed  Google Scholar 

  19. Peitsidis P, Akrivos T, Vecchini G, et al. Splenosis of the peritoneal cavity resembling an adnexal tumor: case report. Clin Exp Obstet Gynecol. 2007;34:120–2.

    CAS  PubMed  Google Scholar 

  20. Vydianath B, Gurumurthy M, Crocker J. Solitary ovarian splenosis. J Clin Pathol. 2005;58:1224–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Doss BJ, Jacques SM, Qureshi F, Ramirez NC, Lawrence WD. Extratubal secondary trophoblastic implants: Clinicopathologic correlation and review of the literature. Hum Pathol. 1998;29:1984–7.

    Google Scholar 

  22. Ali CR, Fitzgerald C. Omental and peritoneal secondary trophoblastic implantation – an unusual complication of IVF. Reprod Biomed Online. 2006;12:776–68.

    Article  PubMed  Google Scholar 

  23. Thacher SSGD, True ID, DeCherney AH. Pelvic trophoblastic implants after laparoscopic treatment of tubal ectopic pregnancy. Fertil Steril. 1989;52:337–9.

    Article  Google Scholar 

  24. Tsutsumi O, Ando K, Momoeda M. Ruptured isthmal pregnancy following laparoscopic sal**ostomy in the ipsilateral tube. Int J Gynaecol Obstet. 1997;57:187–9.

    Article  CAS  PubMed  Google Scholar 

  25. Bucella D, Buxant F, Anaf V, et al. Omental trophoblastic implants after surgical management of ectopic pregnancy. Arch Gynecol Obstet. 2009;280:115–7.

    Article  PubMed  Google Scholar 

  26. Kim KR, Scully RE. Peritoneal keratin granulomas with carcinomas of endometrium and ovary and atypical polypoid adenomyoma of endometrium. A clinico-pathological analysis of 22 cases. Am J Surg Pathol. 1990;14:925–32.

    Article  CAS  PubMed  Google Scholar 

  27. van der Horst C, Evans AJ. Peritoneal keratin granulomas complicating endometrial carcinoma: a report of two cases and review of the literature. Int J Gynecol Cancer. 2008;18:549–53.

    Article  PubMed  Google Scholar 

  28. Kim JY, Jung K-J, Sung NK, et al. Cystic adenomatoid tumor of the uterus. Am J Roentgen. 2002;179:1068–70.

    Article  Google Scholar 

  29. Daya D, McCaughey WT. Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer. 1990;65:292–6.

    Article  CAS  PubMed  Google Scholar 

  30. Hoekstra AV, Riben MW, Frumovitz M, et al. Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol. 2005;98:161–7.

    Article  PubMed  Google Scholar 

  31. Goldblum J, Hart WR. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinic-pathological study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas and localized fibrous tumor. Am J Surg Pathol. 1995;19:1124–37.

    Article  CAS  PubMed  Google Scholar 

  32. Baker PM, Clement PB, Young RH. Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Am J Clin Pathol. 2005;123:724–37.

    Article  PubMed  Google Scholar 

  33. Churg A, Allen T, Borczuk AC, et al. We-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol. 2014;38:990–8.

    Article  PubMed  Google Scholar 

  34. Sawh RN, Malpica A, Deavers MT, et al. Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status. Hum Pathol. 2003;34:369–74.

    Article  CAS  PubMed  Google Scholar 

  35. Attanoos R, Gibbs AR. Pathology of malignant mesothelioma. Histopathology. 1997;30:403–18.

    Article  CAS  PubMed  Google Scholar 

  36. Baker PM, Clement PB, Young RH. Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Am J Clin Pathol. 1999;123:724–37.

    Article  Google Scholar 

  37. Hemminki K, Li X. Time trends and occupational risk factors for peritoneal mesothelioma in Sweden. J Occup Environ Med. 2003;45:451–5.

    Article  PubMed  Google Scholar 

  38. Allen TC, Cagle PT, Churg AM, et al. Localized malignant mesothelioma. Am J Surg Pathol. 2005;29:866–73.

    Article  PubMed  Google Scholar 

  39. Rekhi B, Pathuthara S, Ajit D, et al. “Signet-ring” cells-a caveat in the diagnosis of a diffuse peritoneal mesothelioma occurring in a lady presenting with recurrent ascites: an unusual case report. Diagn Cytopathol. 2010;38:435–9.

    PubMed  Google Scholar 

  40. Shanks JH, Harris M, Banerjee SS, et al. Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females. Am J Surg Pathol. 2000;24:285–94.

    Article  CAS  PubMed  Google Scholar 

  41. Attanoos RL, Webb R, Dojcinov SD, et al. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology. 2002;40:237–44.

    Article  CAS  PubMed  Google Scholar 

  42. Comin CE, Saieva C, Messerini L. H-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol. 2007;31:1139–48.

    Article  PubMed  Google Scholar 

  43. Fois AG, Pirina P, Arcadu A, et al. Desmoplastic small round cell tumors of the pleura: a review of clinical literature. Multidiscip Respir Med. 2017;19:12–22.

    Google Scholar 

  44. Ordonez NG. Desmoplastic small round cell tumor: I: a histopathologic study of 39 cases with emphasis on unusual histological patterns. Am J Surg Pathol. 1998;22:1303–13.

    Article  CAS  PubMed  Google Scholar 

  45. Ordonez NG. Desmoplastic small round cell tumor: II: an ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am J Surg Pathol. 1998;22:1314–27.

    Article  CAS  PubMed  Google Scholar 

  46. Zhang PJ, Goldblum JR, Pawel BR, et al. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol. 2003;16:229–35.

    Article  PubMed  Google Scholar 

  47. Barcena C, Oliva E. WT1 expression in the female genital tract. Adv Anat Pathol. 2011;18:454–65.

    Article  CAS  PubMed  Google Scholar 

  48. Gerald WL, Ladanyi M, de Alava E, et al. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol. 1998;16:3028–36.

    Article  CAS  PubMed  Google Scholar 

  49. Kim J, Lee K, Pelletier J. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties. Oncogene. 1998;16:1973–9.

    Article  CAS  PubMed  Google Scholar 

  50. Ordi J, de Alava E, Torne A, et al. Intraabdominal desmoplastic small round cell tumor with EWS/ERG fusion transcript. Am J Surg Pathol. 1998;22:1026–32.

    Article  CAS  PubMed  Google Scholar 

  51. Coffin CM, Watterson J, Priest JR, et al. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859–72.

    Article  CAS  PubMed  Google Scholar 

  52. Coffin CM, Dehner LP, Meis-Kindblom JM. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol. 1998;15:102–10.

    CAS  PubMed  Google Scholar 

  53. Griffin CA, Hawkins AL, Dvorak C, et al. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res. 1999;59:2776–80.

    CAS  PubMed  Google Scholar 

  54. Treissman SP, Gillis DA, Lee CL, et al. Omental- mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor. Cancer. 1994;73:1433–7.

    Article  CAS  PubMed  Google Scholar 

  55. Brunnemann RB, Ro JY, Ordonez NG, et al. Extrapleural solitary fibrous tumor: a clinicopathologic study of 24 cases. Mod Pathol. 1999;12:1034–42.

    CAS  PubMed  Google Scholar 

  56. Young RH, Clement PB, McCaughey WT. Solitary fibrous tumors ('fibrous mesotheliomas') of the peritoneum. A report of three cases and a review of the literature. Arch Pathol Lab Med. 1990;114:493–5.

    CAS  PubMed  Google Scholar 

  57. Morimitsu Y, Nakajima M, Hisaoka M, et al. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway. APMIS. 2000;108:617–25.

    Article  CAS  PubMed  Google Scholar 

  58. Mosquera JM, Fletcher CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component—is this dedifferentiated SFT? Am J Surg Pathol. 2009;33:1314–21.

    Article  PubMed  Google Scholar 

  59. Vallat-Decouuvelaere A-V, Dry SM, Fletcher CDM. Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol. 1998;22:1501–11.

    Article  Google Scholar 

  60. Gonzalez-Crussi F, deMello DE, Sotelo-Avila C. Omental-mesenteric myxoid hamartomas. Infantile lesions simulating malignant tumors. Am J Surg Pathol. 1983;7:567–78.

    Article  CAS  PubMed  Google Scholar 

  61. Sugarbaker PH, Ronnett BM, Archer A, et al. Pseudomyxoma peritonei syndrome. Adv Surg. 1996;30:233–80.

    CAS  PubMed  Google Scholar 

  62. Brueggen C, Baird G, Meisheid A. Pseudomyxoma peritonei syndrome of appendiceal origin: an overview. Clin J Oncol Nurs. 2007;11:525–32.

    Article  PubMed  Google Scholar 

  63. Fox H. Pseudomyxoma peritonei. Br J Obstet Gynaecol. 1996;103:197–8.

    Article  CAS  PubMed  Google Scholar 

  64. Szych C, Staebler A, Connolly DC, et al. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol. 1999;154:1849–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Ronnett BM, Shmookler BM, Diener-West M, et al. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol. 1997;16:1–9.

    Article  CAS  PubMed  Google Scholar 

  66. Marquette S, Amant F, Vergote I, et al. Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report. Int J Gynecol Pathol. 2006;25:340–3.

    Article  PubMed  Google Scholar 

  67. Ronnett BM, Seidman JD. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol. 2003;27:650–7.

    Article  PubMed  Google Scholar 

  68. Vang R, Gown AM, Zhao C, et al. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol. 2007;31:854–69.

    Article  PubMed  Google Scholar 

  69. Hart WR. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol. 2005;24:4–25.

    PubMed  Google Scholar 

  70. Panarelli NC, Yantiss RK. Mucinous neoplasms of the appendix and peritoneum. Arch Pathol Lab Med. 2011;135:1261–8.

    Article  PubMed  Google Scholar 

  71. Ronnett BM, Kurman RJ, Shmookler BM, et al. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol. 1997;21:1144–55.

    Article  CAS  PubMed  Google Scholar 

  72. Ronnett BM, Yan H, Kurman RJ, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92:85–91.

    Article  CAS  PubMed  Google Scholar 

  73. Baratti D, Kusamura S, Deraco M. The fifth international workshop on peritoneal surface malignancy (Milan, Italy, December 4–6, 2006): methodology of disease-specific consensus. J Surg Oncol. 2008;98:258–62.

    Article  PubMed  Google Scholar 

  74. Ferguson AW, Katabuchi H, Ronnett BM, et al. Glial implants in gliomatosis peritonei arise from normal tissue, not from the associated teratoma. Am J Pathol. 2001;159:51–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Ehdaivand S, Simon RA, Sung CJ, Steinhoff MM, Lawrence WD, Quddus MR. Incidental gynecologic neoplasms in morcellated uterine specimens: a case series with follow-up. Hum Pathol. 2014;45:2311–7.

    Article  PubMed  Google Scholar 

  76. Lauchlan SC. Conceptual unity of the Mullerian tumor group: a histologic study. Cancer. 1968;22:601–10.

    Article  CAS  PubMed  Google Scholar 

  77. Lauchlan SC. The secondary mullerian system revisited. Int J Gynecol Pathol. 1994;13:73–9.

    Article  CAS  PubMed  Google Scholar 

  78. Quddus MR, Sung CJ, Lauchlan SC. Benign and malignant serous and endometrioid epithelium in the omentum. Gynecol Oncol. 1999;75:227–32.

    Article  CAS  PubMed  Google Scholar 

  79. Quddus MR, Sung CJ, Zhang C, Moore RG, Ou J, Steinhoff MM, Lawrence WD. The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a Clinicopathologic study of 188 cases. Hum Pathol. 2012;43:747–52.

    Article  PubMed  Google Scholar 

  80. Mingels MJ, van Ham MA, de Jievit IM, et al. Mullerian precursor lesions in serous ovarian cancer patients: using SEE-Fim and SEE-End protocol. Mod Pathol. 2014;27:1002–13.

    Article  PubMed  Google Scholar 

  81. Klymneko Y, Kim O, Stack MS. Complex determinants of epithelial: mesenchymal phenotypic plasticity in ovarian cancer. Cancers (Basal). 2017;9:104. https://doi.org/10.3390/cancers9080104.

    Article  CAS  Google Scholar 

  82. Piek JM, van Diest PJ, Zweemer RP, et al. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to develo** ovarian cancer. J Pathol. 2001;195:451–6.

    Article  CAS  PubMed  Google Scholar 

  83. Crum CP, Drapkin R, Miton A, et al. The distal fallopian tube: a new model of pelvic serous carcinogenesis. Curr Opin Obstet Gynecol. 2007;19:3–9.

    Article  PubMed  Google Scholar 

  84. Singh N, Gilks CB, Wilkinson N, McCluggage WG. Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal. Histopathology. 2014;65:149–54.

    Article  PubMed  Google Scholar 

  85. Singh R, Cho KR. Serous tubal intraepithelial carcinoma or not? Metastases to fallopian tube can masquerade as in-situ lesions. Arch Pathol Lab Med. 2017;141:1313–5.

    Article  PubMed  Google Scholar 

  86. Rabban JT, Vohra P, Zaloudek CJ. Nongynecologic metastasis to fallopian tube mucosa. A potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia o mucinous hyperplasia. A. J Surg Pathol. 2015;39:35–51.

    Article  Google Scholar 

  87. McCluggage WG, Hirschowtz L, Golks CB, Wolkinson N, Singh N. The fallopian tube origin and primary site assignment in extrauterine high-grade serous carcinoma. Findings of a survey of pathologist and clinicians. Int J Gynecol Pathol. 2016;36:230–9. https://doi.org/10.1097/PGP.0000000000000336.

    Article  Google Scholar 

  88. Singh K, Sung CJ, Lawrence WD, Quddus MR. Testosterone induced "virilization" of mesonephric duct remnants and cervical squamous epithelium in female-to-male transgenders: a report of three cases. Int J Gyncol Pathol. 2017;36:328–33.

    Article  CAS  Google Scholar 

  89. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumours: histologic features and prognosis. Cancer. 1988;62:2212–22.

    Article  CAS  PubMed  Google Scholar 

  90. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol. 1996;20:1331–45.

    Article  CAS  PubMed  Google Scholar 

  91. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol. 1996;20:1319–30.

    Article  CAS  PubMed  Google Scholar 

  92. Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol. 2001;25:419–32.

    Article  CAS  PubMed  Google Scholar 

  93. Gilks CB, Alkushi A, Yue JJ, et al. Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. Int J Gynecol Pathol. 2003;22:29–36.

    Article  PubMed  Google Scholar 

  94. Longacre TA, McKenney JK, Tazelaar HD, et al. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long- term (> or =5-year) follow-up. Am J Surg Pathol. 2005;29:707–23.

    Article  PubMed  Google Scholar 

  95. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000;31:539–57.

    Article  CAS  PubMed  Google Scholar 

  96. Silva EG, Gershenson DM, Malpica A, et al. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol. 2006;30:1367–71.

    Article  PubMed  Google Scholar 

  97. Gershenson DM, Silva EG, Tortolero-Luna G, et al. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer. 1998;83:2157–63.

    Article  CAS  PubMed  Google Scholar 

  98. Schmeler KM, Gershenson DM. Low-grade serous ovarian cancer: a unique disease. Curr Oncol Rep. 2008;10:519–23.

    Article  PubMed  Google Scholar 

  99. Quddus MR, Rashid LB, Hansen K, et al. High-grade serous carcinoma arising in a low-grade serous carcinoma and micropapillary serous borderline tumor of the ovary in a 23- year-old woman. Histopathology. 2009;54:771–3.

    Article  PubMed  Google Scholar 

  100. Poujade O, Uzan C, Gouy S, et al. Primary psammocarcinoma of the ovary or peritoneum. Int J Gynecol Cancer. 2009;19:844–6.

    Article  PubMed  Google Scholar 

  101. Bodnar L, Wcislo G, Gornas M, et al. Serous peritoneal psammocarcinoma with an aggressive course: a case and review of the literature. Ginekol Pol. 2009;80:632–6.

    PubMed  Google Scholar 

  102. Fromm GL, Gershenson DM, Silva EG. Papillary serous carcinoma of the peritoneum. Obstet Gynecol. 1990;75:89–95.

    CAS  PubMed  Google Scholar 

  103. Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007;31:161–9.

    Article  PubMed  Google Scholar 

  104. Leeper K, Garcia R, Swisher E, et al. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol. 2002;87:52–6.

    Article  PubMed  Google Scholar 

  105. Levine DA, Argenta PA, Yee CJ, et al. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. J Clin Oncol. 2003;21:4222–7.

    Article  CAS  PubMed  Google Scholar 

  106. Frank TS, Manley SA, Olopade OI, et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutation s with family history and ovarian cancer risk. J Clin Oncol. 1998;16:2417–25.

    Article  CAS  PubMed  Google Scholar 

  107. Breast Cancer Linkage Consortium. Cancer risk in BRCA2 mutation carriers. J Natl Can Inst. 1999;91:1310–6.

    Article  Google Scholar 

  108. Lim S, Kim JY, Park K, et al. Mullerianosis of the mesosalpinx: a case report. Int J Gynecol Pathol. 2003;22:209–12.

    Article  PubMed  Google Scholar 

  109. Heretis J, Stamatiou V, Papadimitriou V, et al. Endocervicosis of the bladder report of a case and review of the current literature. Int J Clin Exp Pathol. 2009;2:91–4.

    PubMed  Google Scholar 

  110. Banerjee R, Gough J. Cystic mucinous tumors of the mesentery and retroperitoneum: report of three cases. Histopathology. 1988;12:527–32.

    Article  CAS  PubMed  Google Scholar 

  111. Pearl ML, Valea F, Chumas J, et al. Primary retroperitoneal mucinous cystadenocarcinoma of low malignant potential: a case report and literature review. Gynecol Oncol. 1996;61:150–2.

    Article  CAS  PubMed  Google Scholar 

  112. Park U, Han KC, Chang HK, et al. A primary mucinous cystoadenocarcinoma of the retroperitoneum. Gynecol Oncol. 1991;42:64–7.

    Article  CAS  PubMed  Google Scholar 

  113. Altinok G, Usubutun A, Kucukali T, et al. Disseminated peritoneal leiomyomatosis. A benign entity mimicking carcinomatosis. Arch Gynecol Obstet. 2000;264:54, 55.

    Article  Google Scholar 

  114. Heinig J, Neff A, Cirkel U, et al. Recurrent leiomyomatosis peritonealis disseminata after hysterectomy and bilateral sal**o-oophorectomy during combined hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol. 2003;111:216–8.

    Article  CAS  PubMed  Google Scholar 

  115. Due W, Pickartz H. Immunohistologic detection of estrogen and progesterone receptors in disseminated peritoneal leiomyomatosis. Int J Gynecol Pathol. 1989;8:46–53.

    Article  CAS  PubMed  Google Scholar 

  116. Fulcher AS, Szucs RA. Leiomyomatosis peritonealis disseminata complicated by sarcomatous transformation and ovarian torsion: presentation of two cases and review of the literature. Abdom Imaging. 1998;23:640–4.

    Article  CAS  PubMed  Google Scholar 

  117. Prade M, Spatz A, Bentley R, Dullivard P, Bognel C, Robboy SJ. Borderline and malignant serous tumors arising in pelvic lymph nodes: evidence of origin in benign glandular inclusions. Int J Gynecol Pathol. 1995;14:87–91.

    Article  CAS  PubMed  Google Scholar 

  118. Horn LC, Bilek K. Frequency and histogenesis of pelvic retroperitoneal lymph node inclusions of the female genital tract. An immunohistochemical study of 34 cases. Pathol Res Pract. 1995;191:991–6.

    Article  CAS  PubMed  Google Scholar 

  119. Kheir SM, Mann WJ, Wilkerson JA. Glandular inclusions in lymph nodes. The problem of extensive involvement and relationship to sal**itis. Am J Surg Pathol. 1981;5:353–9.

    Article  CAS  PubMed  Google Scholar 

  120. Hsu YK, Rosenshein NB, Parmley TH, et al. Leiomyomatosis in pelvic lymph nodes. Obstet Gynecol. 1981;57:91S–3S.

    CAS  PubMed  Google Scholar 

  121. Horie A, Ishii N, Matsumoto M, et al. Leiomyomatosis in the pelvic lymph node and peritoneum. Acta Pathol Jpn. 1984;34:813–9.

    CAS  PubMed  Google Scholar 

  122. Aslan i M, Ahn GH, Scully RE. Serous papillary cystadenoma of borderline malignancy of broad ligament. A report of 25 cases. Int J Gynecol Pathol. 1988;7:131–8.

    Article  Google Scholar 

  123. Altaras MM, Jaffe R, Corduba M, et al. Primary paraovarian cystadenocarcinoma: clinical and management aspects and literature review. Gynecol Oncol. 1990;38:268–72.

    Article  CAS  PubMed  Google Scholar 

  124. Altaras M, Rosen D, Shapira J, et al. Advanced primary ovarian carcinoma in pregnancy. Am J Obstet Gynecol. 1989;160:1210–1.

    Article  CAS  PubMed  Google Scholar 

  125. Cox R, Vang R, Epstein JI. Papillary cystadenoma of the epididymis and broad ligament: morphologic and immunohistochemical overlap with clear cell papillary renal cell carcinoma. Am J Surg Pathol. 2014;38:713–8.

    Article  PubMed  Google Scholar 

  126. Kariminejad MH, Scully RC. Female adnexal tumor of probable Wolffian origin. Cancer. 1973;31:671–7.

    Article  CAS  PubMed  Google Scholar 

  127. Fukunaga M, Bisceglia M, Dimitri L. Endometrioid carcinoma of the fallopian tube resembling a female adnexal tumor of probable Wolffian origin. Adv Anat Pathol. 2004;11:269–72.

    Article  PubMed  Google Scholar 

  128. Zheng W, Senturk BZ, Parkash V. Inhibin immunohistochemical staining: a practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors. Adv Anat Pathol. 2003;10:27–38.

    Article  PubMed  Google Scholar 

  129. Brescia RJ, Cardoso de Almeida PC, Fuller AF Jr, et al. Female adnexal tumor of probable Wolffian origin with multiple recurrences over 16 years. Cancer. 1985;56:1456–61.

    Article  CAS  PubMed  Google Scholar 

  130. Bell DA, Woodruff JM, Scully RE. Ependymoma of the broad ligament. A report of two cases. Am J Surg Pathol. 1984;8:203–9.

    Article  CAS  PubMed  Google Scholar 

  131. Yamamoto Y, Takehara K, Okame S, Komatsu M, Shiroyama Y, Yokoyama T. A case of ependymoma arising from the peritoneum. Int Can Conf J. 2016;5:121–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Warren Alpert Medical School of Brown University, Women & Infants Hospital, Providence, RI, USA

    M. Ruhul Quddus & C. James Sung

  2. Department of Pathology and Laboratory Medicine, Allegheny Health Network West Penn Hospital, Drexel University College of Medicine, and Temple University School of Medicine, Pittsburgh, PA, USA

    Sharon Liang

  3. Departments of Pathology, Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA

    Wenxin Zheng

Authors
  1. M. Ruhul Quddus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharon Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenxin Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. James Sung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. James Sung .

Editor information

Editors and Affiliations

  1. Department of Pathology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA

    Wenxin Zheng

  2. Department of Pathology, University of California San Diego, San Diego, CA, USA

    Oluwole Fadare

  3. Department of Pathology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA

    Charles Matthew Quick

  4. Department of Pathology, Peking University People’s Hospital, Bei**g, China

    Danhua Shen

  5. Department of Obstetrics and Gynecology, Tian** Gynecologic and Obstetrics Central Hospital, Tian**, China

    Donghui Guo

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Science Press & Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ruhul Quddus, M., Liang, S., Zheng, W., Sung, C.J. (2019). Peritoneum and Broad Ligament. In: Zheng, W., Fadare, O., Quick, C., Shen, D., Guo, D. (eds) Gynecologic and Obstetric Pathology, Volume 2. Springer, Singapore. https://doi.org/10.1007/978-981-13-3019-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-3019-3_11

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-3018-6

  • Online ISBN: 978-981-13-3019-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation